What Our Client Needed
Target had unique experience developing and launching companion diagnostics (CDx) for pharmaceutical products, which had potential to pair with a clinical development player with unique technical capabilities already in client’s portfolio
Our Solution
- Assess key dynamics shaping the CDx development market
- Evaluate differentiation of Target given their niche CDx expertise and product portfolio
- Conduct a targeted, expert-driven assessment to understand the degree to which additional services would be value-additive to current/future customers of current portfolio company
- Assess degree of capabilities overlap and potential for seamless integration into organizational structure
Our Impact
- Developed market map of key players, their capabilities, and current gaps in the CDx market
- Evaluated CDx development process along product journey from conception to approval, to enable articulation of key areas of differentiation
- Provided analysis of Target positioning in CDx market and ability to complement existing portfolio company
- Supported scenario-based revenue forecast modeling
- Outlined key recommendations for roll-up strategy in CDx along with potential alternative investment options
